MAPT and Brain atrophy: The inhibition of CSF1Rs with PLX3397 also rescues tau pathology and brain atrophy in a model with combined tau and amyloid pathologies, showing that DAMs in the proximity of amyloid plaques are resistant to CSF1R inhibition.